Echo IQ (ASX:EIQ)

Reinventing how we look at structural heart disease to make stronger care management decisions using the power of AI

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

At #EchoAustralia? Don't miss @PlayfordDavid's lecture at 10:30 AM today in Hall 3--and be sure to drop by booth 18 to chat with the Echo IQ and @HydrixLtd teams!

@ScaliaGreg @maddiejane25

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

#CVTransforum with @MedAxiom was a resounding success! Our team had such a pleasure meeting cardiovascular leaders from across the US, discussing AI, and sharing our research.

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

We had an excellent time at #ESC2023 presenting multiple studies and reconnecting with our colleagues.

Pictured left to right: Simon Stewart, Greg Scalia, Julie Humphries, David Playford, and Geoff Strange

[David Playford @PlayfordDavid]

Largest study ever performed assessing the mortality association with increasing LV mass from the National Echo Database of Australia, presented @escardio #ESCCongress. New mortality threshold at 88g/m2 for men and 82g/m2 for women. @thecsanz @ASE360 @EchoIQ_AI @ISHBP @EchofirstB

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

We need to consider structural heart disease prognoses with a critical eye--and new tools, like AI, can help us ask harder questions and get greater decision-support.

Thanks and congrats to @PlayfordDavid on his late-breaking science session at #ESCCongress.

#ESC2023

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

What have we seen when we take the latest technologies and apply them to some of the most nuanced disease progression questions in MR? Join us NOW in Vilnius at @escardio! #ESC2023

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

Starting NOW in Vilnius! Don't miss this important late-breaking session covering AI and NLP applied to the world's largest echo database linked to mortality! #ESCCongress #ESC2023 @radcliffeCARDIO

[David Playford @PlayfordDavid]

@EchoIQ_AI Very excited to be presenting our top line results of the mortality associated with no, mild, moderate and severe mitral regurgitation tomorrow - Late Breaking Science session @escardio meeting in Amsterdam. Come and see the presentation as embargo is lifted @ASE360 @thecsanz

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

We're on a roll later this week with two sessions at #ESC2023! These wil highlight the clinical and technical advances our team have made in aortic stenosis and mitral regurgitation detection.

https://t.co/uwppJmBh6B

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

The European Society of Cardiology's 2023 congress is just days away! Here are a few of the things the Echo IQ team is looking forward to the most.

#ESC2023 #LateBreakingScience #aiinhealthcare

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

This was a tough one--but it's a whopping *66%* of women who were under-diagnosed according to our latest clinical cohort study. Find out more on August 27th with Professor Geoff Strange at #ESC2023. Get all the details at https://t.co/qKimUSQi8L

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

Bias in healthcare is a hot topic for a good reason: it harms everyone from the patient to the practitioner. Unconscious biases can be exceptionally treacherous.

How prevalent do you think the underdiagnosis of women with aortic stenosis was in a recent trial?

#ESC2023

[The Market Online AU @marketonlineau]

@EchoIQ_AI (#ASX: $EIQ) announces significant expansion to EchoSolv #cardiology platform

$EIQ COO, Philip Woolff, joins The Market Herald to discuss further ⬇️

Watch the full video interview here: https://t.co/bv5BTRF829

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

Are patients with severe aortic stenosis being missed? If so, we can be done to consistently change that?

Find out at #ESC2023 on August 27th at 14:00 in the Bratislava room!

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

We're looking forward to two important late-breaking science presentations from our team at #ESC2023 this year! Speaking first will be @PlayfordDavid on "MR-NEDA - Prognosis of mild to severe MR": Friday, 25th August at 2pm Vilnius Lecture Hall.

Don't miss it!

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

Bias in healthcare is a hot topic for a good reason: it harms everyone from the patient to the practitioner. Unconscious biases can be exceptionally treacherous.

How prevalent do you think the underdiagnosis of women with aortic stenosis was in a recent trial?

#ESC2023

[Echo IQ (ASX:EIQ) @EchoIQ_AI]

Echo IQ has not one, but TWO late-breaking science sessions at #esc2023!

We're excited to be a part of the @escardio congress for many years in a row now and are looking forward to the conversations on innovation and medical progress with our esteemed colleagues. Join us there!

[Red Leaf Securities @RedLeafSec]

Click below to watch our latest vlog with EchoIQ Ltd COO Philip Woolff on #Vimeo https://t.co/HPGLdkVkkc
$EIQ @EchoIQ_AI #ASX #AI #ausbiz #tradingday

[John McDonald @MaccaPolitical]

Well done @EchoIQ_AI @SHDAust @OpenHeartIntl @HeartResearchAU #aorticvalve @VictorChangInst @SCAA @CardiacConsult @PMunkCardiacCtr #Cardiology

https://t.co/596wJo84AY

[David Playford @PlayfordDavid]

To improve our detection of the AS phenotype, we used an AI system that ignores LVOT measurements and uses the rest of the echo to find those at risk. #echofirst #AI @EchoIQ_AI @ASE360 #esccongress2022 @escardio

[David Playford @PlayfordDavid]

And here are the results - The continuous probability output is divided conveniently into three groups corresponding to no AS, moderate and severe phenotypes. Mortality separation is very clear!
Next step for @EchoIQ_AI is to complete reg approval and commercial product.

[David Playford @PlayfordDavid]

Late breaking science @escardio today - embargo lifted! #AI diagnosis of #aorticstenosis with @EchoIQ_AI. AUCROC 0.98, correctly identified the AS mortality risk phenotypes of severe AS. Will transform @EchofirstB reporting! @evi2prac @thecsanz @ASE360 @BSEcho #tavi #partnership